Sculptra
Related procedures
What the research says about Sculptra (poly-L-lactic acid)
14 peer-reviewed sourcesSculptra is an injectable formulation of poly-L-lactic acid (PLLA), a biocompatible, gradually resorbed material that works as a collagen biostimulator rather than an immediate volume filler. Published clinical studies and systematic reviews report progressive, gradual improvement in facial volume and skin quality over a course of treatments, with results that build over several months and can persist for up to about two years. The evidence base also documents the procedure's safety profile, including the relevance of correct reconstitution, even injection technique, and post-treatment massage to reduce the risk of nodules and papules. Rare but serious vascular events have been described in the literature, underscoring that outcomes depend heavily on an experienced, qualified injector and appropriate patient selection. The references below are drawn from peer-reviewed sources and are provided for general education; they are not a substitute for an individual consultation.
- Optimizing Collagen Biostimulator Choice in LATAM: Expert Consensus on Patient Selection, Ethnic Skin Phenotypes, and Accessibility.
- Comprehensive Systematic Review of Poly-L-Lactic Acid in Facial Clinical Application.
- Efficacy, Durability, and Safety of Collagen Biostimulators Based on Poly-L-Lactic Acid (PLLA) and Calcium Hydroxyapatite (CaHA) in the Face: A Systematic Review.
- Poly-L-Lactic Acid in Aesthetic Dermatology: A Decade Beyond Volume Restoration Toward Regenerative Biostimulation.
- Visual Loss in Biostimulator Injectables: A Review of Incidence, Risk Factors, Etiology and Management Proposal.
Compiled from peer-reviewed medical literature indexed on PubMed. This overview is for general education and is not medical advice. · Last updated 2026-06-15